Grants for clinical and translational research projects. Pilot Funding

Big Ideas, Small Features:
Advanced Microscopic & Nanoscale Technologies

At a glance
Sponsors
Funding Level
  • Up to $50,000 per award
Eligibility
  • All Harvard University-appointed junior and senior faculty members are encouraged to apply.
Requirements
Event Dates
  • April 4 and 11, 2016
Register by
  • 12:00pm on April 7, 2016
Note: Registration is closed. Please check back for future opportunities.
Contact

Offered by Harvard Catalyst's Reactor Program, this pilot funding opportunity will provide up to $50,000 in funding and access to the Harvard Center for Biological Imaging (HCBI), which features advanced Zeiss microscopes, or the Center for Nanoscale Systems (CNS), that offers electron microscopy, nanoscale fabrication, and nanoscale analysis capabilities, or access to both.

Funding will support the innovative application of light and electron microscopy, nanoscale fabrication, and nanoscale analysis technologies for big ideas that will advance clinical healthcare.

To apply, you are required to attend one of two educational events run by the Harvard Catalyst Reactor Program, or meet independently with the facility staff experts of HCBI and/or CNS to learn more about the technologies available and their capabilities.

  • Educational events will be held on Monday, April 4, 2016, and Monday, April 11, at the Biological Labs Building, 16 Divinity Avenue, Cambridge. Each educational session will run from 2:30pm to 4:00pm. Optional Q&A sessions and lab tours will run from 4:00pm to 5:30pm. Registration is required. Further information about the event will be available after registration.
  • If you are unable to attend either of these educational events, you are required to meet with a representative of HCBI and/or CNS personnel to learn about the equipment and technologies available.

Pilot grant proposals should describe innovative research projects that, if successful, could provide new insights into: (1) the application of new technologies to inform clinical decisions; (2) disease detection, causation, progression, or treatment; or (3) the development of new therapeutics, diagnostics, or clinically informative biomarkers. Applications need not be limited to these areas.

Areas of inquiry should focus on translational research and human healthcare. Proposals requiring experiments using non-human samples will also be considered if there is a clear and direct link to subsequent investigation using human specimens. Proposals investigating basic research questions or wholly directed to pre-clinical work will not be considered.

Cite Us

Have you received a Pilot Grant? Remember to cite Harvard Catalyst in your publications and posters.